SEC Form 4 · accession 0001144204-15-050718
Arch Therapeutics, Inc. · ARTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terrence W Norchi
Officer — President, CEO · Director · 10% Owner
Period of report
Aug 18, 2015
Accepted (ET)
Aug 19, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001537561
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $0.28 | Aug 18, 2015 | A | 355,000 | A | — | Aug 17, 2025 | Common Stock | 355,000 | 355,000 | D |
Explanation of responses
- F1Of the Shares subject to the Option, 25% shall vest immediately upon August 18, 2015, and 1/36 of the remaining unvested Shares subject to the Option shall vest on each of the next thirty-six (36) monthly anniversaries.